Advertisement
EMITF vs IQV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMITF is a Hold and IQV is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMITF’s FA Score shows that 1 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).
- EMITF’s FA Score: 1 green, 4 red.
- IQV’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMITF’s TA Score shows that 3 TA indicator(s) are bullish while IQV’s TA Score has 3 bullish TA indicator(s).
- EMITF’s TA Score: 3 bullish, 5 bearish.
- IQV’s TA Score: 3 bullish, 5 bearish.
Price Growth
EMITF (@Financial Conglomerates) experienced а -2.70% price change this week, while IQV (@Medical Specialties) price change was +6.24% for the same time period.
The average weekly price growth across all stocks in the @Financial Conglomerates industry was +4.62%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +55.63%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +3.75%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +1.62%.
Reported Earning Dates
IQV is expected to report earnings on Oct 22, 2025.
Industries' Descriptions
@Financial Conglomerates (+4.62% weekly)Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.
@Medical Specialties (+3.75% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| EMITF | IQV | EMITF / IQV | |
| Capitalization | 20.6M | 32.5B | 0% |
| EBITDA | 7.74M | 3.35B | 0% |
| Gain YTD | 20.000 | -2.758 | -725% |
| P/E Ratio | N/A | 27.69 | - |
| Revenue | 0 | 15.7B | - |
| Total Cash | 42.1M | 2.19B | 2% |
| Total Debt | N/A | 15.7B | - |
EMITF | IQV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 61 | 79 | |
SMR RATING 1..100 | 89 | 46 | |
PRICE GROWTH RATING 1..100 | 56 | 44 | |
P/E GROWTH RATING 1..100 | 100 | 67 | |
SEASONALITY SCORE 1..100 | n/a | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EMITF's Valuation (16) in the Real Estate Development industry is somewhat better than the same rating for IQV (72) in the Servicestothe Health Industry industry. This means that EMITF’s stock grew somewhat faster than IQV’s over the last 12 months.
EMITF's Profit vs Risk Rating (61) in the Real Estate Development industry is in the same range as IQV (79) in the Servicestothe Health Industry industry. This means that EMITF’s stock grew similarly to IQV’s over the last 12 months.
IQV's SMR Rating (46) in the Servicestothe Health Industry industry is somewhat better than the same rating for EMITF (89) in the Real Estate Development industry. This means that IQV’s stock grew somewhat faster than EMITF’s over the last 12 months.
IQV's Price Growth Rating (44) in the Servicestothe Health Industry industry is in the same range as EMITF (56) in the Real Estate Development industry. This means that IQV’s stock grew similarly to EMITF’s over the last 12 months.
IQV's P/E Growth Rating (67) in the Servicestothe Health Industry industry is somewhat better than the same rating for EMITF (100) in the Real Estate Development industry. This means that IQV’s stock grew somewhat faster than EMITF’s over the last 12 months.
| EMITF | IQV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 44% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 52% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 51% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 51% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 46% | 2 days ago 66% |
| Advances ODDS (%) | N/A | 4 days ago 60% |
| Declines ODDS (%) | N/A | 16 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 64% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 53% | 2 days ago 48% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DDLS | 41.40 | 0.05 | +0.11% |
| WisdomTree Dynamic Intl SmCap Eq ETF | |||
| IBDQ | 25.14 | 0.02 | +0.08% |
| iShares iBonds Dec 2025 Term Corp ETF | |||
| AIEQ | 43.94 | N/A | +0.01% |
| Amplify AI Powered Equity ETF | |||
| RSMC | 25.78 | -0.31 | -1.18% |
| Rockefeller U.S. Small-Mid Cap ETF | |||
| IWML | 20.30 | -0.67 | -3.20% |
| ETRACS 2x Leveraged US Size Fctr TR ETN | |||
EMITF and
Correlation & Price change
A.I.dvisor tells us that EMITF and AVHHL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EMITF and AVHHL's prices will move in lockstep.
| Ticker / NAME | Correlation To EMITF | 1D Price Change % | ||
|---|---|---|---|---|
| EMITF | 100% | N/A | ||
| AVHHL - EMITF | 26% Poorly correlated | N/A | ||
| KLYG - EMITF | 24% Poorly correlated | N/A | ||
| ASAPF - EMITF | 24% Poorly correlated | -9.87% | ||
| IQV - EMITF | 23% Poorly correlated | +0.89% | ||
| PHG - EMITF | 15% Poorly correlated | +0.88% | ||
More | ||||
IQV and
Correlation & Price change
A.I.dvisor indicates that over the last year, IQV has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IQV jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
|---|---|---|---|---|
| IQV | 100% | +0.89% | ||
| SYK - IQV | 54% Loosely correlated | +0.90% | ||
| ALC - IQV | 51% Loosely correlated | +1.06% | ||
| ATR - IQV | 50% Loosely correlated | +0.27% | ||
| NVST - IQV | 49% Loosely correlated | -0.86% | ||
| QDEL - IQV | 48% Loosely correlated | -0.08% | ||
More | ||||